New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study
Tarih
2017Yazar
Gedikli, Omer
Sinan, Umit Yasar
BEŞLİ, FEYZULLAH
Tok, Ozge Ozden
Cakmak, Huseyin Altug
Altay, Servet
Yildirimturk, Ozlem
Askin, Lutfu
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.
Bağlantı
http://hdl.handle.net/20.500.12627/124696https://doi.org/10.14744/anatoljcardiol.2016.7472
Koleksiyonlar
- Makale [92796]